Healthcare provider profile · identity verified

Roberta Jo Wedl, MD

Family Practice · WHITEWATER, WI · NPI 1497706600

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	649	164
Levothyroxine Sodium	Levothyroxine Sodium	514	108
Omeprazole	Omeprazole	444	103
Amlodipine Besylate	Amlodipine Besylate	353	81
Lisinopril	Lisinopril	333	88
Losartan Potassium	Losartan Potassium	327	80
Furosemide	Furosemide	289	61
Metoprolol Succinate	Metoprolol Succinate	282	78
Gabapentin	Gabapentin	224	53
Famotidine	Famotidine	204	44
Trazodone Hcl	Trazodone Hcl	195	45
Hydrochlorothiazide	Hydrochlorothiazide	188	47
Sertraline Hcl	Sertraline Hcl	188	43
Warfarin Sodium	Warfarin Sodium	184	33
Simvastatin	Simvastatin	182	51
Rosuvastatin Calcium	Rosuvastatin Calcium	178	50
Metoprolol Tartrate	Metoprolol Tartrate	159	37
Escitalopram Oxalate	Escitalopram Oxalate	154	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	144	29
Potassium Chloride	Potassium Chloride	142	37
Eliquis	Apixaban	127	31
Alendronate Sodium	Alendronate Sodium	124	30
Spironolactone	Spironolactone	124	26
Pantoprazole Sodium	Pantoprazole Sodium	121	28
Atenolol	Atenolol	113	28
Tamsulosin Hcl	Tamsulosin Hcl	113	22
Metformin Hcl Er	Metformin Hcl	103	31
Montelukast Sodium	Montelukast Sodium	102	20
Carvedilol	Carvedilol	100	20
Fluticasone Propionate	Fluticasone Propionate	99	45
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	95	19
Donepezil Hcl	Donepezil Hcl	87	15
Glipizide Er	Glipizide	85	19
Mirtazapine	Mirtazapine	85	21
Memantine Hcl	Memantine Hcl	80	11
Duloxetine Hcl	Duloxetine Hcl	76	15
Paroxetine Hcl	Paroxetine Hcl	72	16
Lovastatin	Lovastatin	70	18
Metformin Hcl	Metformin Hcl	70	18
Lorazepam	Lorazepam	69	22
Albuterol Sulfate Hfa	Albuterol Sulfate	60	31
Clopidogrel	Clopidogrel Bisulfate	57	13
Breo Ellipta	Fluticasone/Vilanterol	55	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	55	20
Allopurinol	Allopurinol	54	16
Fluoxetine Hcl	Fluoxetine Hcl	54	20
Oxybutynin Chloride Er	Oxybutynin Chloride	54	13
Ezetimibe	Ezetimibe	51	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	48	34
Enalapril Maleate	Enalapril Maleate	46	13
Myrbetriq	Mirabegron	46	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	46	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	45	12
Finasteride	Finasteride	44	12
Clonazepam	Clonazepam	43	suppressed
Irbesartan	Irbesartan	41	suppressed
Hydrocortisone	Hydrocortisone	40	suppressed
Nystatin	Nystatin	40	12
Hydralazine Hcl	Hydralazine Hcl	39	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	suppressed
Amoxicillin	Amoxicillin	37	24
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Digoxin	Digoxin	34	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	34	15
Ozempic	Semaglutide	33	suppressed
Azithromycin	Azithromycin	32	19
Oxybutynin Chloride	Oxybutynin Chloride	32	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	30	21
Propranolol Hcl Er	Propranolol Hcl	30	suppressed
Alprazolam	Alprazolam	29	11
Levetiracetam	Levetiracetam	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	12
Phenytoin Sodium Extended	Phenytoin Sodium Extended	28	suppressed
Aripiprazole	Aripiprazole	27	suppressed
Bumetanide	Bumetanide	27	suppressed
Cholestyramine	Cholestyramine (With Sugar)	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Cephalexin	Cephalexin	25	19
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Folic Acid	Folic Acid	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Prednisone	Prednisone	23	18
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Estradiol	Estradiol	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Metronidazole	Metronidazole	20	suppressed
Loperamide	Loperamide Hcl	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Meloxicam	Meloxicam	18	suppressed
Naproxen	Naproxen	18	suppressed
Nitroglycerin	Nitroglycerin	18	14
Tramadol Hcl	Tramadol Hcl	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	13
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Nyamyc	Nystatin	15	suppressed
Olanzapine	Olanzapine	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Lactulose	Lactulose	13	suppressed
Naltrexone Hcl	Naltrexone Hcl	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Methylprednisolone	Methylprednisolone	12	11
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Prevalite	Cholestyramine	12	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	12	suppressed
Topiramate	Topiramate	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Diazepam	Diazepam	11	suppressed
Nadolol	Nadolol	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error